Dr. Craig Brown, MD

Claim this profile

St-John Regional Hospital

Studies Acute Kidney Injury
Studies Coronary Artery Disease
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.

St. John Regional Hospital

Image of trial facility.

Horizon Health Network, Saint John Regional Hospital

Clinical Trials Craig Brown, MD is currently running

Image of trial facility.

Single vs Multiple Arterial Grafts

for Heart Disease

The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grfating (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and cerebrovascular events in women undergoing coronary artery bypass grfating (CABG). The investigators will compare major adverse cardiac and cerebrovascular events (death, stroke, non-procedural myocardial infarction, repeat revascularization, and hospital readmission for acute coronary syndrome or heart failure) in a cohort of 2,000 women randomized 1:1 to MAG or SAG (690 from the parent ROMA trial + 1,310 from ROMA:Women). Differences by important clinical and surgical subgroups (patients younger or older than 70 years, diabetics, racial and ethnic minorities, on vs off pump CABG, type of arterial grafts used) will also be evaluated. The women enrolled in the ongoing ROMA trial (anticipated to be approximately 690) will be included in ROMA:Women, increasing efficiency and reducing enrollment time. Hypothesis 1.0. MAG will reduce the incidence of major adverse cardiac and cerebrovascular events. Hypothesis 1.1. The improvement with MAG will be consistent across key subgroups. Aim 2: Determine the impact of MAG vs SAG on generic and disease-specific QOL, physical and mental health symptoms in women undergoing CABG. The investigators will compare generic (SF-12, EQ-5D) and disease-specific (Seattle Angina Questionnaire) QOL and physical and mental health symptoms (PROMIS-29) in a sub-cohort of 500 women randomized 1:1 to MAG or SAG (including those enrolled in ROMA:QOL). Differences by important subgroups (as defined above) will also be evaluated. Hypothesis 2.0. MAG will improve generic and disease-specific QOL compared to SAG. Hypothesis 2.1. MAG will improve physical and mental health symptoms compared to SAG. Hypothesis 2.2. The improvement with MAG will be consistent across key subgroups.

Recruiting

1 award

N/A

4 criteria

More about Craig Brown, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Craig Brown, MD has experience with

  • RBT-1
  • Multiple Arterial Grafting
  • Single Arterial Graft

Breakdown of trials Craig Brown, MD has run

Acute Kidney Injury

Coronary Artery Disease

Heart Disease

Coronary Artery Bypass Surgery

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Craig Brown, MD specialize in?

Is Craig Brown, MD currently recruiting for clinical trials?

Are there any treatments that Craig Brown, MD has studied deeply?

What is the best way to schedule an appointment with Craig Brown, MD?

What is the office address of Craig Brown, MD?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.